Bandaram Pharma

{
  "main_header": {
    "sid": 365157,
    "name": "Bandaram Pharma",
    "stock_name": "Bandaram Pharma",
    "full_name": "Bandaram Pharma Packtech Ltd",
    "name_url": "stocks-analysis/bandaram-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.15",
    "chg": 0.3,
    "chgp": "1.21%",
    "dir": 1,
    "prev_price": "24.85",
    "mcapval": "43.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524602,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "India SENSEX",
    "isin": "INE875N01036",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "699 ",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bandaram-pharma-365157-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3963058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_mojoScore_3963058.png",
        "date": "2026-04-26 10:10:24",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3945503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_mojoScore_3945503.png",
        "date": "2026-04-14 10:10:36",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3930076",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_mojoScore_3930076.png",
        "date": "2026-04-02 10:10:41",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd Falls to 52-Week Low of Rs 22 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-ltd-falls-to-52-week-low-of-rs-22-3928361",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_priceRelatedfactors_3928361.png",
        "date": "2026-04-01 09:41:22",
        "description": "For the fourth consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 22 on 1 Apr 2026. This marks a steep 20.03% drop over the last four days, underscoring persistent selling pressure despite a broadly positive market backdrop."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3900028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BandaramPharmaP_mojoScore_3900028.png",
        "date": "2026-03-19 10:10:49",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3873055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BandaramPharmaP_mojoScore_3873055.png",
        "date": "2026-03-05 10:10:53",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3844099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BandaramPharmaP_mojoScore_3844099.png",
        "date": "2026-02-17 10:10:54",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd Valuation Shifts to Very Attractive Amid Mixed Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-ltd-valuation-shifts-to-very-attractive-amid-mixed-market-performance-3843253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BandaramPharmaP_valuationdot_3843253.png",
        "date": "2026-02-17 08:01:37",
        "description": "Bandaram Pharma Packtech Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating despite lingering concerns over its profitability metrics and market performance. This recalibration in price-to-earnings and price-to-book value ratios invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group within the healthcare services sector."
      },
      {
        "title": "Are Bandaram Pharma Packtech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bandaram-pharma-packtech-ltd-latest-results-good-or-bad-3838242",
        "imagepath": "",
        "date": "2026-02-13 20:01:14",
        "description": "Bandaram Pharma Packtech Ltd's latest financial results for Q2 FY26 present a complex picture. The company achieved a significant year-on-year revenue growth of 92.97%, with net sales reaching ₹13.72 crores, marking the highest quarterly revenue in its history. This growth reflects the company's ability to scale operations within the recycled paper processing sector. However, this top-line success is starkly contrasted by a substantial decline in profitability. The net profit for the quarter was ₹0.06 crores, which represents a dramatic 91.04% decrease compared to the same period last year, highlighting severe operational inefficiencies.\n\nThe operating profit margin fell to 3.35%, the lowest in recent quarters, indicating challenges in cost management and operational efficiency. This margin compression occurred despite the revenue surge, raising concerns about the company's ability to convert sales growth i..."
      }
    ],
    "total": 143,
    "sid": "365157",
    "stock_news_url": "https://www.marketsmojo.com/news/bandaram-pharma-packtech-365157"
  },
  "announcements": [
    {
      "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Bandaram Pharma Packtech Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L93090KA1993PLC159827</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Neha Kankariya</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Siva Kumar Vellanki</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Bandaram Pharma Packtech Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L93090KA1993PLC159827</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>3.48</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Neha Kankariya <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: infoshivamedicare@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Siva Kumar Vellanki <br/> Designation: CFO <br/> EmailId: infoshivamedicare@gmail.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "27-Apr-2026",
      "details": "Outcome of EGM of the company for FY 2026-27 held on 27.04.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has declared <strong>1%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has announced <strong>3:1</strong> rights issue, ex-date: 30 Jun 23",
          "dt": "2023-06-30",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Bandaram Pharma Packtech Ltd is Rated Sell

2026-04-26 10:10:24

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-04-14 10:10:36

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date analysis of the company’s standing.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-04-02 10:10:41

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bandaram Pharma Packtech Ltd Falls to 52-Week Low of Rs 22 as Sell-Off Deepens

2026-04-01 09:41:22

For the fourth consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 22 on 1 Apr 2026. This marks a steep 20.03% drop over the last four days, underscoring persistent selling pressure despite a broadly positive market backdrop.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-03-19 10:10:49

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-03-05 10:10:53

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-02-17 10:10:54

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bandaram Pharma Packtech Ltd Valuation Shifts to Very Attractive Amid Mixed Market Performance

2026-02-17 08:01:37

Bandaram Pharma Packtech Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating despite lingering concerns over its profitability metrics and market performance. This recalibration in price-to-earnings and price-to-book value ratios invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group within the healthcare services sector.

Read full news article

Are Bandaram Pharma Packtech Ltd latest results good or bad?

2026-02-13 20:01:14

Bandaram Pharma Packtech Ltd's latest financial results for Q2 FY26 present a complex picture. The company achieved a significant year-on-year revenue growth of 92.97%, with net sales reaching ₹13.72 crores, marking the highest quarterly revenue in its history. This growth reflects the company's ability to scale operations within the recycled paper processing sector. However, this top-line success is starkly contrasted by a substantial decline in profitability. The net profit for the quarter was ₹0.06 crores, which represents a dramatic 91.04% decrease compared to the same period last year, highlighting severe operational inefficiencies. The operating profit margin fell to 3.35%, the lowest in recent quarters, indicating challenges in cost management and operational efficiency. This margin compression occurred despite the revenue surge, raising concerns about the company's ability to convert sales growth i...

Read full news article

View All News